论文部分内容阅读
迄今为止 ,前列腺特异抗原 (prostatespecificantigen ,PSA)已被公认为检测前列腺癌 (Pca)最具临床价值的瘤标 ,美国FDA已经同意应用PSA结合DRE检查对 5 0岁以上男性进行筛查 ,可有助于早期诊断前列腺癌。但PSA是前列腺组织特异性的?
So far, prostatespecificantigen (PSA) has been recognized as the most clinically valuable tumor marker for detecting prostate cancer (Pca). The U.S. FDA has agreed to screen for males over the age of 50 with PSA-DRE. Help early diagnosis of prostate cancer. But PSA is prostate tissue specific?